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Analysis of health service amenable and non-amenable mortality before and
since China's expansion of health coverage in 2009
Abstract
Objective To explore early impacts of China's health reforms in 2009 on mortality. Methods Annual
mortality counts were obtained from 161 counties across all 31 provinces of mainland China between
2006 and 2012. We examined time-series of health service amenable mortality counts, including separate
analyses for deaths from stroke and ischaemic heart diseases (IHD). Non-amenable mortality counts,
including separate models for oesophageal and pancreatic cancers, were also analysed as part of a
negative-outcome strategy to provide stronger foundations for falsification. Deaths due to amenable
causes were hypothesised to decrease, whereas non-amenable causes of mortality would remain
uninfluenced. All analyses were conducted using multilevel negative binomial regression. Results
Geographical variation was observed for each mortality indicator, especially for IHD, oesophageal and
pancreatic cancers. Negative covariances in all models indicated slight degrees of convergence in these
geographic variations over time (but not significantly for deaths from oesophageal and pancreatic
cancers). Linear and square functions of time indicated a curvilinear inverted parabolic trend between
2006 and 2012 for stroke and IHD mortality. Reduction in health-service amenable mortality over time
was observed, but also for health service non-amenable mortality, including deaths from oesophageal
cancer. Pancreatic cancer was found to increase across the study period. In counties where residents had
more years of education, mortality from stroke was lower and reducing faster over time. A similar
spatiotemporal patterning was observed for deaths from oesophageal cancer, and health service
amenable and non-amenable causes. Counties with higher mean education years had higher mortality
from IHD and pancreatic cancer, but also larger reductions in mortality were evident in areas with greater
years of education. Conclusions Although there was no clear evidence of an early impact of China's health
reform on mortality, this does not rule out potentially important contributions to reducing the burden of
disease in the longer term.
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ABSTRACT
Objective: To explore early impacts of China’s health
reforms in 2009 on mortality.

Methods: Annual mortality counts were obtained from
161 counties across all 31 provinces of mainland
China between 2006 and 2012. We examined timeseries of health service amenable mortality counts,
including separate analyses for deaths from stroke and
ischaemic heart diseases (IHD). Non-amenable
mortality counts, including separate models for
oesophageal and pancreatic cancers, were also
analysed as part of a negative-outcome strategy to
provide stronger foundations for falsification. Deaths
due to amenable causes were hypothesised to
decrease, whereas non-amenable causes of mortality
would remain uninfluenced. All analyses were
conducted using multilevel negative binomial
regression.
Results: Geographical variation was observed for each
mortality indicator, especially for IHD, oesophageal and
pancreatic cancers. Negative covariances in all models
indicated slight degrees of convergence in these
geographic variations over time (but not significantly
for deaths from oesophageal and pancreatic cancers).
Linear and square functions of time indicated a
curvilinear inverted parabolic trend between 2006 and
2012 for stroke and IHD mortality. Reduction in healthservice amenable mortality over time was observed,
but also for health service non-amenable mortality,
including deaths from oesophageal cancer. Pancreatic
cancer was found to increase across the study period.
In counties where residents had more years of
education, mortality from stroke was lower and
reducing faster over time. A similar spatiotemporal
patterning was observed for deaths from oesophageal
cancer, and health service amenable and non-amenable
causes. Counties with higher mean education years
had higher mortality from IHD and pancreatic cancer,
but also larger reductions in mortality were evident in
areas with greater years of education.
Conclusions: Although there was no clear evidence of
an early impact of China’s health reform on mortality,
this does not rule out potentially important
contributions to reducing the burden of disease in the
longer term.

Strengths and limitations of this study
▪ Annual mortality time-series data from 161 locations across all 31 provinces of China.
▪ Multilevel random intercept-slope models to
investigate spatiotemporal variation.
▪ Recognised classification of health service
‘amenable’ mortality.
▪ Use of ‘negative outcome’ technique with health
service ‘non-amenable’ mortality.
▪ Data on geographic variation in health policy
implementation is needed.

INTRODUCTION
Commentators suggest that a universal
health insurance which provides access to
good quality health services not only helps
enhance health and prevents disease,1 but
also serves to reduce socioeconomic
inequity2 and strengthens the workforce.3
The pursuit for universal health coverage has
been reﬂected in developments over the past
10–15 years in China, including the landmark reforms of 2009. China’s government
began to re-establish rural health insurance
from 2002 in which all rural Chinese residents were eligible to enrol.4 Attention then
focused on cities with the launch of the
urban resident basic health insurance in
2007.5 This was followed by China’s landmark reforms in 2009, which led to the rapid
expansion of health insurance to over 90%
of the population by the end of 2010.6 Five
years on, we investigated whether the
Chinese government’s investment of CN¥850
billion (US$125 billion) had early impacts
on public health.
While universal health coverage is
regarded as central to social and economic
policy3 and a vital component for achieving
health equity,7 the scientiﬁc evidence of
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health its impact is mixed.8 Population-wide investigations of the impact of universal health insurance are
rare,9 with most focusing either on young children10–13
or the elderly.14 15 Previous work on the implementation
of universal health coverage from 1995 onwards in
Taiwan, for example, has reported a rise in health
service utilisation among the newly insured16 and a marginally steeper rise in life expectancy within communities that had higher mortality rates before 1995.17 Yet
both favourable and null ﬁndings have been reported
on possible improvements in health status and reductions in mortality.18 19 The potential health impact of
implementing universal health coverage is uncertain in
a society as socially and geographically diverse as
China.20 Furthermore, given the proliferation of particular diseases and causes of death amenable to healthcare
intervention in particular areas of China, it is unlikely
that any early impacts on health have been uniform
across this vast country.
Accordingly, the aim of our study was to use a nationally representative time series data (2006–2012) across
mainland China spanning the period prior and subsequent to the 2009 reform to explore for early impacts of
the expansion of universal coverage on public health.

population of approximately 73 million people, including
urban and rural counties in all 31 provinces, municipalities and autonomous regions within China. Amenable
mortality (table 1) and other mortality counts were stratiﬁed by year, gender and age group (50–59 years, 60–
69 years, 70–79 years, 80+ years) at the DSP level for years
2006–2012 inclusive. Population counts from the 2010
census were used to ascertain denominators.
Table 1 Amenable mortality definition
No Name

Age

ICD10

1
2

Intestinal infections
Tuberculosis

0–14
0–74

3

Other infectious (diphtheria,
tetanus, poliomyelitis)
Whooping cough
Septicaemia
Measles
Malignant neoplasm of colon
and rectum
Malignant neoplasm of skin
Malignant neoplasm of breast
Malignant neoplasm of cervix
uteri
Malignant neoplasm of cervix
uteri and body of the uterus
Malignant neoplasm of testis
Hodgkin’s disease
Leukaemia
Diseases of the thyroid
Diabetes mellitus
Epilepsy
Chronic rheumatic heart
disease
Hypertensive disease

0–74
0–14
0–74
1–14
0–74

A00-A09
A15-A19,
B90
A36, A35,
A80
A37
A40-A41
B05
C18-C21

0–74
0–74
0–74

C44
C50
C53

0–44

C54, C55

0–74
0–74
0–44
0–74
0–49
0–74
0–74

C62
C81
C91-C95
E00-E07
E10-E14
G40-G41
I05-I09

0–74

I10-I13,
I15
I20-I25
I60-I69
J00-J09,
J20-J99

4
5
6
7
8
9
10
11

METHODS
Assessments of possible change in disease incidence and
associated risk factors at this present time are unlikely to
yield substantial ﬁndings given that near-universal health
coverage was only recently achieved in China and the
lag-times on these outcomes make them more suitable
to long-term follow-up. However, the inﬂuence of the
exogenous expansion in health coverage may be observable within the short-term by tracking ‘health service
amenable mortality’21 before and subsequent to 2009.
The hypothesis is that the near-universal health coverage
will have helped to raise standards of living, enhance
health promotion and promoted greater equity of access
to life-saving health services. The impact would then
manifest in downward trends in mortality attributable to
preventable causes, such as stroke and ischaemic heart
disease (IHD).
To enhance this pre–post time-series analysis we leveraged a negative outcome study design22 wherein causes of
death that could not have been affected by the health
reforms were also analysed. This analysis of so-called
‘negative outcomes’ provides additional foundations for
falsiﬁability of the main hypothesis that expansion of
health service coverage had a favourable impact on health
service amenable mortality. For this purpose, we selected
oesophageal and pancreatic cancers speciﬁcally due to
their short survival times,23 24 as well as the broader group
of mortality causes that are not classiﬁed as ‘amenable’.
Access to annual mortality counts for 161 ‘disease surveillance points’ (DSP) was provided by the Chinese
Center for Disease Control and Prevention (China CDC).
The DSP is nationally representative and covers a sample
2

12
13
14
15
16
17
18
19

20 Ischaemic heart disease
21 Cerebrovascular disease
22 All respiratory diseases
(excluding pneumonia/
influenza)
23 Influenza
24 Pneumonia
25 Peptic ulcer
26 Appendicitis
27 Abdominal hernia
28 Cholelithiasis and cholecystitis
29 Nephritis and nephrosis

30 Benign prostatic hyperplasia
31 Maternal deaths
32 Congenital cardiovascular
anomalies
33 Perinatal deaths, all causes
excluding stillbirths
34 Misadventures to patients
during surgical and medical
care

0–74
0–74
1–14

0–74
0–74
0–74
0–74
0–74
0–74
0–74

0–74
All
0–74
All
All

J10-J11
J12-J18
K25-K27
K35-K38
K40-K46
K80-K81
N00-N07,
N17-N19,
N25-N27
N40
O00-O99
Q20-Q28
P00-P96,
A33, A34
Y60-Y69,
Y83-Y84
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Socioeconomic circumstances were measured using the
mean years of education among residents within each
DSP, also extracted from the 2010 census.
Descriptive analysis was conducted by calculating the
mean annual mortality count for each cause of death for
2006–2012 inclusive. Statistical analysis was conducted via
multilevel negative binomial regression with random coefﬁcients to investigate potential spatiotemporal variation in
each mortality count.25 An assumption of a standard
random intercept multilevel model is that the relationship
between and outcome and exposure is the same regardless of the higher level unit, such as a geographic area. By
ﬁtting a random coefﬁcient between DSPs and time in
our models, we allowed the relationship between mortality
and time to vary between DSPs, henceforth making potential geographic deviations in mortality trends (ie, spatiotemporal variation) more observable.
Initial models were ﬁtted with gender, age group and
year as ﬁxed effects. The year variable was ﬁtted as in
the form of linear and square terms to explore for
potential curvilinear trends. This was to help account for
the hierarchical data structure, wherein each DSP-level
mortality count was stratiﬁed by gender, age group and
year. Henceforth, level 1 within the model was the
DSP-level mortality count for every combination of
gender, age group and year, nested within DSPs at level
2. Linear and square functions of year were ﬁtted into
the model to assess for deviation in the mortality trends
through time. The degree of potential spatiotemporal
variation was assessed by observing the covariance of the
random slopes. DSP-level variances were re-expressed as
median rate ratios (MRR). The DSP-level mean years of
education was then added to each model along with an
interaction with year to explore whether there was
change in the level of socioeconomic inequity over the
time period. All ﬁxed effect parameters were exponentiated to rate ratios (RR) and 95% CIs. All analyses were
conducted in MLwIN V.2.30 using penalised quasilikelihood with second order Taylor series expansion to
correct for downwardly biased variances.
RESULTS
Mean health service amenable mortality was observed at
151.5/100 000 in 2006, rising to 164.1/100 000 by 2008,
but then decreasing from 2009 onwards to 150.7/

100 000 by 2012 (table 2). Stroke mortality appeared to
follow a similar inverted parabolic trend, whereas IHD
mortality increased across the study period.
Non-amenable mortality increased from 453.7/100 000
in 2006 to 495.0/100 000 in 2008, falling to 487.2/
100 000 by 2012. Mortality from pancreatic cancer
increased across the study period, but deaths from
oesophageal cancer decreased.
Substantial geographical variation was observed for
mortality counts from stroke (MRR 1.76), IHD (1.99;
table 3), oesophageal cancer (2.76) and pancreatic
cancer (1.95; table 4). The spatial patterning of health
service amenable (1.49) and non-amenable (1.28) mortality counts was less varied by comparison (table 5). In
models unadjusted for socioeconomic circumstances
(model 1s, tables 3–5), stroke and IHD mortality
increased but then curved downward over time period
(table 3). Deaths from oesophageal cancer also reduced
but those from pancreatic cancer increased (table 4).
Both health service amenable and non-amenable causes
of death appeared to decline across the study period
(table 5). The covariances indicated a slight narrowing
of the geographic variation of these mortality counts
through the study period.
Adjusting for socioeconomic circumstances did not
markedly change these results. Higher mean years of
education in a DSP was associated with lower mortality
from stroke, oesophageal, health service amenable and
non-amenable mortality, but also higher IHD and pancreatic cancer mortality. Interaction terms indicated
some degree of change in the socioeconomic patterning
of each mortality outcome over time, with potential narrowing of the gradient for IHD and pancreatic cancer,
but widening for other causes of death due to larger
reductions in areas with greater years of education.
DISCUSSION
Unprecedented change in built, physical and socioeconomic environments associated with rapid urbanisation have manifested unevenly across China, presenting
major challenges in disease prevention and detection.26 27 The expansion of health coverage in China as
a result of the 2009 reforms has been interpreted an
important step towards ensuring access to healthcare
and protecting health in the long term. In the short

Table 2 Mortality count for each cause of death per 100 000 people, by year
Year

Amenable

Ischaemic
heart disease

Stroke

Non-amenable

Pancreatic
cancer

Oesophageal
cancer

2006
2007
2008
2009
2010
2011
2012

151.5
154.6
164.1
155.3
151.6
152.6
150.7

58.5
70.3
78.3
81.7
85.6
89.8
96.4

120.0
127.7
144.8
141.9
142.6
141.7
141.6

453.7
468.6
495.0
473.2
471.1
469.9
478.2

3.2
3.7
3.7
3.7
3.7
4.2
4.1

12.3
13.0
12.7
11.9
11.1
10.8
10.7
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Table 3 Spatiotemporal trajectories and socioeconomic inequities in mortality from stroke and ischaemic heart disease
Stroke mortality
Model 1

Model 2

Ischaemic heart disease mortality
Model 1
Model 2

Fixed part
Rate Ratio (95% CI)
Year
1.08 (1.04 to 1.13)
1.09 (1.05 to 1.13)
1.10 (1.07 to 1.12)
1.10 (1.07 to 1.13)
Year2
0.99 (0.98 to 0.99)
0.99 (0.98 to 0.99)
0.99 (0.99 to 0.99)
0.99 (0.99 to 0.99)
Gender (ref: male)
Female
0.55 (0.54 to 0.57)
0.55 (0.54 to 0.57)
0.45 (0.43 to 0.46)
0.45 (0.43 to 0.46)
Age group (ref: 50–59 years)
60–69
2.92 (2.84 to 2.99)
2.92 (2.84 to 2.99)
2.58 (2.51 to 2.65)
2.58 (2.51 to 2.65)
70–79
9.77 (9.52 to 10.02)
9.77 (9.52 to 10.02)
8.28 (8.06 to 8.51)
8.28 (8.06 to 8.51)
80+
25.53 (24.89 to 26.19) 25.53 (24.89 to 26.19) 28.65 (27.87 to 29.44) 28.65 (27.87 to 29.44)
Gender×age group (years)
Female×60–69
1.10 (1.06 to 1.15)
1.10 (1.06 to 1.15)
1.37 (1.32 to 1.43)
1.37 (1.32 to 1.43)
Female×70–79
1.25 (1.21 to 1.30)
1.25 (1.21 to 1.30)
1.77 (1.70 to 1.84)
1.77 (1.70 to 1.84)
Female×80+
1.47 (1.41 to 1.52)
1.47 (1.41 to 1.52)
2.07 (1.98 to 2.15)
2.07 (1.98 to 2.15)
Mean years of
0.96 (0.90 to 1.02)
1.16 (1.08 to 1.25)
education
Year×Mean years of
0.94 (0.91 to 0.96)
0.97 (0.95 to 0.98)
education
Year2×Mean years of
1.01 (1.00 to 1.01)
1.00 (1.00 to 1.01)
education
Random part
DSP×Year
Intercept variance
0.350 (0.041) [1.76]
0.347 (0.041) [1.75]
0.521 (0.060) [1.99]
0.485 (0.056) [1.94]
(SE) [MOR]
Covariance (SE)
−0.094 (0.015)
−0.101 (0.015)
−0.043 (0.010)
−0.036 (0.010)
Slope variance (SE)
0.060 (0.008)
0.051 (0.007)
0.018 (0.003)
0.016 (0.003)
DSP×Year2
Intercept variance
0.010 (0.002) [1.10]
0.011 (0.002) [1.11]
0.004 (0.001) [1.06]
0.003 (0.001) [1.05]
(SE) [MOR]
Covariance (SE)
−0.007 (0.001)
−0.006 (0.001)
−0.002 (<0.001)
−0.002 (<0.001)
Slope variance (SE)
0.001 (<0.001)
0.001 (<0.001)
<0.001 (<0.001)
<0.001 (<0.001)
DSP, disease surveillance point; MRR, median rate ratio.

term, has the expansion of health insurance in China
had appreciable and early beneﬁts or not? Building on
recent work,28 29 our study found mixed evidence for
early impacts on mortality. Evidence in support of an
early beneﬁt was from the declines in mortality from
health service amenable causes. The curvilinear trend of
stroke and IHD mortality (rising initially then falling), is
not at odds with wider literature on the nutrition transition in China30–32 but is insufﬁcient to discount an early
beneﬁt of the health reform on its own. The concurrent
upward trajectory in deaths from pancreatic cancer,
which would not be expected to be inﬂuenced by the
expansion of health coverage, lends support. However,
declines in oesophageal cancer mortality and nonamenable causes more generally suggests that reductions
in amenable mortality cannot be solely attributed to the
2009 health reform.
The provision of universal health insurance remains a
fundamental determinant of health33 and the equivocal
ﬁndings from our study do not rule out the likely social
and economic beneﬁts experienced in many communities across mainland China. A full appreciation of the
costs and beneﬁts will only become clearer over time

and with epidemiological studies on a range of health
outcomes, including time-series analyses of mortality
counts. The classiﬁcation of mortality into causes of
death that are recognised to be health service amenable
and non-amenable21 has been previously used to assess
the impact of a health insurance coverage expansion in
Taiwan.18 Our ﬁndings are similar in that mortality from
amenable and non-amenable causes decreased during
the study period. This comparison afforded a negative
outcome study design,22 a method which provides stronger grounds for assessing the potential impacts of the
health reform intervention. It should be noted, however,
that the negative outcome approach does not necessarily
provide strong evidence for or against causation. The
degree of health coverage policy implementation and
beneﬁts likely varied across China but we do not have
access to data with which to measure that spatiotemporal
diffusion and variation in exposure. It is plausible, for
example, that while the less socioeconomically well-off
areas and rural communities in particular could have
potentially beneﬁtted most from the health reform,
these communities may also have been less likely to
receive full implementation of the policy within the

4
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Table 4 Spatiotemporal trajectories and socioeconomic inequities in mortality from oesophageal and pancreatic cancers
Oesophageal cancer mortality
Model 1
Model 2
Fixed part
Year
Year2
Gender (ref: male)
Female
Age group (ref: 50–59 years)
60–69
70–79
80+
Gender×age group (years)
Female×60–69
Female×70–79
Female×80+
Mean years of education
Year×Mean years of education
Year2×Mean years of
education
Random part
DSP×Year
Intercept variance (SE)
[MOR]
Covariance (SE)
Slope variance (SE)

Pancreatic cancer mortality
Model 1
Model 2

Rate ratio (95% CI)
0.98 (0.95 to 1.00)
1.00 (0.99 to 1.00)

0.96 (0.93 to 0.99)
1.00 (0.99 to 1.00)

1.04 (1.01 to 1.08)
1.00 (0.99 to 1.00)

1.06 (1.02 to 1.10)
0.99 (0.99 to 1.00)

0.20 (0.19 to 0.21)

0.23 (0.21 to 0.24)

0.59 (0.55 to 0.64)

0.59 (0.55 to 0.64)

2.38 (2.28 to 2.49)
4.67 (4.47 to 4.87)
6.85 (6.52 to 7.19)

2.44 (2.31 to 2.56)
4.84 (4.60 to 5.09)
7.10 (6.72 to 7.50)

2.26 (2.12 to 2.42)
4.59 (4.30 to 4.89)
6.01 (5.55 to 6.50)

2.27 (2.13 to 2.41)
4.56 (4.29 to 4.86)
5.91 (5.48 to 6.36)

1.42 (1.31 to 1.54)
1.81 (1.67 to 1.95)
2.06 (1.89 to 2.24)

1.39 (1.28
1.72 (1.58
1.88 (1.71
0.87 (0.77
0.97 (0.95
1.00 (1.00

to 1.52)
to 1.88)
to 2.06)
to 0.98)
to 0.99)
to 1.01)

1.14 (1.02 to 1.26)
1.27 (1.15 to 1.41)
1.26 (1.12 to 1.42)

1.13 (1.02
1.26 (1.14
1.26 (1.12
1.34 (1.25
0.98 (0.96
1.00 (1.00

1.189 (0.139) [2.83]

0.488 (0.066) [1.95]

1.131 (0.133) [2.76]
−0.024 (0.017)
0.008 (0.003)

−0.022 (0.016)
0.003 (0.004)

−0.027 (0.015)
0.003 (0.005)

to 1.25)
to 1.39)
to 1.40)
to 1.44)
to 1.00)
to 1.01)

0.343 (0.049) [1.75]
−0.007 (0.012)
0.002 (0.005)

DSP, disease surveillance point; MRR, median rate ratio.

study period. Were these data to become available to
empirically test, it would be possible to compare trends
in mortality over time in ‘treated’ compared with
‘untreated’ communities within a regression discontinuity framework—an important and under-used study
design for evaluations of the causal impact of large-scale
policies on health.34 35
Previous research conducted on China’s health
reforms provide important context for the ﬁndings. A
large repeated cross-sectional study conducted in 2003,
2008 and 2011 assessed trends in access to healthcare
coverage, healthcare activities and ﬁnancial protection.36
That study reported an increase in healthcare coverage
from 29.7% in 2003 to 95.7% by 2011, indicating a dramatic narrowing of inequity of access across regions and
between the poorest and wealthiest. However, this was
accompanied by a notable increase in hospital admissions.37 In 2011, 12.9% of households had health
expenses described as ‘catastrophic’, with rural residents
described as being particularly vulnerable. Another
study, focusing on Shaanxi Province in the west of
China, reported decreasing medicine prices but also
reductions in the availability of the lowest-priced generic
medicines in the public and private sectors between
2010 and 2012.38 This underlines our hypothesis that
while healthcare insurance has achieved virtually universal coverage in China, there are other related factors
such as the availability of medicines and substantial
health expenses that are likely to vary geographically
and, henceforth, shape spatial inequities in health

outcomes. Further research with large sources of routinely collected administrative data, as well as bespoke
surveys and qualitative research, are clearly required in
order to fully understand the impact of health reforms
in China.
Further strengths of our study include the wide geographical scope of the data spanning all 31 provinces
and the analyses of disease-speciﬁc causes of mortality
for comparison purposes. The latter was demonstrably
important given the different levels of geographic variation and temporal trajectories in mortality. Although
deaths from causes that are and are not amenable to
health service intervention are typically grouped separately, an appreciation of heterogeneity within these
groups is similarly crucial. It is nonetheless vital to note
that DSPs can be very large and within-DSP spatial heterogeneity is unobservable with the data available and,
therefore, masks changes in mortality trends at a more
local scale and inequities between different population
groups, such as urban migrants who do not have permanent residency status within China’s megacities.39
It is important to acknowledge that the routine surveillance of mortality counts across a country as vast as
China is not trivial. One key challenge is underreporting of mortality counts. Previous research40 using
the DSP mortality data analysed in this study found signiﬁcantly higher under-reporting of mortality in rural
compared with urban areas.41 Explanations for this geographic variation in under-reporting are numerous and
could potentially include less experienced medical and
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Table 5 Spatiotemporal trajectories and socioeconomic inequities in mortality from health service amenable and
non-amenable causes
Health service amenable mortality
Model 1
Model 2

Health service non-amenable mortality
Model 1
Model 2

Fixed part
Rate Ratio (95% CI)
Year
0.98 (0.97 to 1.00)
0.98 (0.97 to 1.00)
0.98 (0.96 to 0.99)
0.98 (0.97 to 0.99)
Year2
1.00 (1.00 to 1.00)
1.00 (1.00 to 1.00)
1.00 (1.00 to 1.00)
1.00 (1.00 to 1.00)
Gender (ref: male)
female
0.63 (0.62 to 0.64)
0.63 (0.62 to 0.64)
0.44 (0.43 to 0.45)
0.44 (0.43 to 0.45)
Age group (ref: 50–59 years)
60–69
2.74 (2.70 to 2.78)
2.74 (2.70 to 2.78)
2.08 (2.05 to 2.12)
2.08 (2.05 to 2.12)
70–79
4.21 (4.15 to 4.28)
4.21 (4.15 to 4.28)
7.94 (7.82 to 8.07)
7.94 (7.82 to 8.07)
80+
0.00 (0.00 to 0.00)
0.00 (0.00 to 0.00)
27.19 (26.77 to 27.62)
27.19 (26.77 to 27.62)
Gender×age group (years)
female×60–69
1.05 (1.02 to 1.07)
1.05 (1.02 to 1.07)
1.16 (1.13 to 1.18)
1.16 (1.13 to 1.18)
female×70–79
1.10 (1.07 to 1.12)
1.10 (1.07 to 1.12)
1.49 (1.46 to 1.53)
1.49 (1.46 to 1.53)
female×80+
0.80 (0.38 to 1.68)
0.80 (0.38 to 1.68)
1.83 (1.79 to 1.87)
1.83 (1.79 to 1.87)
Mean years of education
0.89 (0.86 to 0.93)
0.92 (0.90 to 0.95)
0.98 (0.97 to 0.99)
0.99 (0.98 to 1.00)
Year×Mean years of
education
Year2×Mean years of
1.00 (1.00 to 1.00)
1.00 (1.00 to 1.00)
education
Random part
DSP×Year
Intercept variance (SE)
0.176 (0.021) [1.49]
0.148 (0.017) [1.44]
0.068 (0.008) [1.28]
0.054 (0.007) [1.25]
[MOR]
Covariance (SE)
−0.003 (0.003)
−0.007 (0.003)
−0.008 (0.002)
−0.009 (0.002)
Slope variance (SE)
0.005 (0.001)
0.004 (0.001)
0.004 (0.001)
0.004 (0.001)
DSP, disease surveillance point; MRR, median rate ratio.

(rather than adhere to a ﬁxed slope for the entire
country). This is an important methodological strength
since, as we have already reﬂected on, it is unlikely that
all areas of China witnessed the same level of change
postreform within the short time period of this study.
Further work is warranted in this regard to ascertain
how much change had occurred in terms of healthcare
provision at a local level.
In conclusion, mixed ﬁndings in this time-series analysis of health service amenable mortality and negative
outcomes indicate that it may be too early to identify
appreciable beneﬁts of the expansion of health coverage
across China. Far from refuting the position that universal healthcare is an essential social good, our study
demonstrates the need for more in-depth epidemiological investigation on the potential beneﬁts for health
status, lifestyle and health service use related factors that
may yet determine clear reductions in amenable mortality across China.

administrative staff in rural areas, as well as lower levels
of willingness among some bereaved families in rural
areas to report deaths.42 43 A study has been published
comparing compared capture-mark-recapture techniques using a household survey as gold standard, based
on a set of assumptions,44 with propensity score techniques to address under-reporting in China’s DSP mortality data.40 The authors found the propensity score
approach to correct more accurately for under-reporting
and it is that adjusted data set that we have analysed in
this study. It should be acknowledged, however, that
death information for China’s ‘ﬂoating’ population (eg,
urban migrants without permanent residency) is incomplete and could not be analysed as a distinct group
within this study.
By focusing on mortality and a relatively short study
period of 7 years, including 3 years both prior and subsequent to the 2009 health reforms, other early beneﬁts
could not be assessed. These may include better geographical access to healthcare and health promotion
activities that enhance community well-being, the results
of which are more likely to emerge much later. A limitation of the analysis is that the DSP system, at 161 locations, did not contain information on the healthcare
environments provided in each area during the time
period. Our use of random coefﬁcient multilevel models
circumvented this limitation to a degree by allowing
mortality trajectories for every DSP to vary over time

Author affiliations
1
Early Start Research Institute, University of Wollongong, Wollongong, New
South Wales, Australia
2
School of Health and Society, University of Wollongong, Wollongong, New
South Wales, Australia
3
National Center for Noncommunicable and Chronic Disease Control and
Prevention, China Center for Disease Control and Prevention, Beijing, China
4
School of Science and Health, Western Sydney University, Sydney, New
South Wales, Australia

6

Feng X, et al. BMJ Open 2016;6:e009370. doi:10.1136/bmjopen-2015-009370

Downloaded from http://bmjopen.bmj.com/ on May 11, 2016 - Published by group.bmj.com

Open Access
5

Centre for Health Research, School of Medicine, Western Sydney University,
Sydney, New South Wales, Australia

20.

Contributors XF, TA-B and MZ conceptualised and designed the study. XF
and YL conducted the statistical analyses. PY, SL, JL, LW and MZ conducted
data collection, cleaning and participated data analysis. AP contributed to data
interpretation. XF wrote the first and final draft of the manuscript. All
co-authors contributed to the interpretation of results and redrafting of the
manuscript.

21.

Funding This study received funding from the Australian-China Science and
Research Fund. XF is supported by a UIC International Links Scheme. TA-B is
supported by a National Heart Foundation of Australia Postdoctoral Fellowship
(#100161).

22.
23.

24.
25.

Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/

26.
27.
28.

29.
30.

REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.

Evans DB, Marten R, Etienne C. Universal health coverage is a
development issue. Lancet 2012;380:864–5.
Moreno-Serra R, Smith PC. Does progress towards universal health
coverage improve population health? Lancet 2012;380:917–23.
Frenk J, de Ferranti D. Universal health coverage: good health, good
economics. Lancet 2012;380:862–4.
State Council and Central Committee of Communist Party of China.
Decisions on further strengthening rural health development. Beijing,
2002.
Tang S, Tao J, Bekedam H. Controlling cost escalation of
healthcare: making universal health coverage sustainable in China.
BMC Public Health 2012;12(Suppl 1):S8.
Yip WC-M, Hsiao WC, Chen W, et al. Early appraisal of China’s
huge and complex health-care reforms. Lancet 2012;379:833–42.
Marmot M, Friel S, Bell R, et al. Closing the gap in a generation:
health equity through action on the social determinants of health.
Lancet 2008;372:1661–9.
Levy H, Meltzer D. The impact of health insurance on health. Annu
Rev Public Health 2008;29:399–409.
Kolstad JT, Kowalski AE. The impact of health care reform on
hospital and preventive care: evidence from Massachusetts. J Public
Econ 2012;96:909–29.
Currie J, Gruber J. Health insurance eligibility, utilization of medical
care, and child health. National Bureau of Economic Research, 1995.
Currie J, Gruber J. Saving babies: the efficacy and cost of recent
expansions of Medicaid eligibility for pregnant women. National
Bureau of Economic Research, 1994.
Hanratty MJ. Canadian national health insurance and infant health.
Am Econ Rev 1996;86:276–84.
Chou S-Y, Grossman M, Liu J-T. The impact of national health
insurance on birth outcomes: a natural experiment in Taiwan.
National Bureau of Economic Research, 2011.
Finkelstein A. The aggregate effects of health insurance: evidence
from the introduction of medicare. Q J Econ 2007;122:1–37.
Card D, Dobkin C, Maestas N. Does medicare save lives? National
Bureau of Economic Research, 2007.
Shou-Hsia C, Tung-Liang C. The effect of universal health insurance
on health care utilization in Taiwan: results from a natural
experiment. JAMA 1997;278:89–93.
Wen CP, Tsai SP, Chung W-SI. A 10-year experience with universal
health insurance in Taiwan: measuring changes in health and health
disparity. Ann Intern Med 2008;148:258–67.
Lee Y-C, Huang Y-T, Tsai Y-W, et al. The impact of universal
National Health Insurance on population health: the experience of
Taiwan. BMC Health Serv Res 2010;10:225.
Chen L, Yip W, Chang MC, et al. The effects of Taiwan’s National
Health Insurance on access and health status of the elderly. Health
Econ 2007;16:223–42.

Feng X, et al. BMJ Open 2016;6:e009370. doi:10.1136/bmjopen-2015-009370

31.

32.
33.

34.

35.
36.
37.
38.

39.
40.

41.
42.
43.

44.

Yu SC, Tan F, Zhou MG, et al. Global burden of disease, injury and
risk factor study 2010: its policy implications for China. Biomed
Environ Sci 2014;27:45–8.
Nolte E, McKee M. Measuring the health of nations: analysis of
mortality amenable to health care. BMJ 2003;327:1129.
Lipsitch M, Tchetgen ET, Cohen T. Negative controls: a tool for
detecting confounding and bias in observational studies.
Epidemiology 2010;21:383–8.
Conlon KC, Klimstra DS, Brennan MF. Long-term survival after
curative resection for pancreatic ductal adenocarcinoma.
Clinicopathologic analysis of 5-year survivors. Ann Surg
1996;223:273.
Dubecz A, Gall I, Solymosi N, et al. Temporal trends in long-term
survival and cure rates in esophageal cancer: a SEER database
analysis. J Thorac Oncol 2012;7:443–7.
Leyland AH, Goldstein H. Multilevel modelling of health statistics.
Chichester, UK: Wiley, 2001.
Chan CK, Yao X. Air pollution in mega cities in China. Atmos
Environ 2008;42:1–42.
Zhou M, Astell-Burt T, Bi Y, et al. Geographical variation in diabetes
prevalence and detection in China: multilevel spatial analysis of
98,058 adults. Diabetes Care 2015;38:72–81.
Astell-Burt T, Liu Y, Feng X, et al. Health reform and mortality in
China: multilevel time-series analysis of regional and
socioeconomic inequities in a sample of 73 million. Sci Rep
2015;5:15038–8.
Zhou M, Astell-Burt T, Yin P, et al. Spatiotemporal variation in
diabetes mortality in China: multilevel evidence from 2006 and 2012.
BMC Public Health 2015;15:633.
Adair L, Gordon-Larsen P, Du S, et al. The emergence of
cardiometabolic disease risk in Chinese children and adults:
consequences of changes in diet, physical activity and obesity.
Obes Rev 2014;15(Suppl 1):49–59.
Du S, Wang H, Zhang B, et al. China in the period of transition from
scarcity and extensive undernutrition to emerging nutrition-related
non-communicable diseases, 1949–1992. Obes Rev
2014;15(Suppl 1):8–15.
Zhai F, Du S, Wang Z, et al. Dynamics of the Chinese diet and
the role of urbanicity, 1991–2011. Obes Rev 2014;15(Suppl 1):
16–26.
Commission on Social Determinants of Health. Closing the gap in a
generation: health equity through action on the social determinants
of health: Final Report of the Commission on Social Determinants of
Health. Geneva, Switzerland: WHO, 2008.
Moscoe E, Bor J, Bärnighausen T. Regression discontinuity designs
are underutilized in medicine, epidemiology, and public health:
a review of current and best practice. J Clin Epidemiol
2015;68:122–33.
Bor J, Moscoe E, Bärnighausen T. Three approaches to causal
inference in regression discontinuity designs. Epidemiology 2015;26:
e28–30.
Meng Q, Xu L, Zhang Y, et al. Trends in access to health services
and financial protection in China between 2003 and 2011:
a cross-sectional study. Lancet 2012;379:805–14.
Wang S, Liu L, Li L, et al. Comparison of Chinese inpatients with
different types of medical insurance before and after the 2009
healthcare reform. BMC Health Serv Res 2014;14:443.
Fang Y, Wagner AK, Yang S, et al. Access to affordable medicines
after health reform: evidence from two cross-sectional surveys in
Shaanxi Province, Western China. Lancet Glob Health 2013;1:
e227–37.
Gusmano MK, Rodwin VG, Wang C, et al. Shanghai rising: health
improvements as measured by avoidable mortality since 2000. Int J
Health Policy Manag 2015;4:7–12.
Guo K, Yin P, Wang L, et al. Propensity score weighting for
addressing under-reporting in mortality surveillance:
a proof-of-concept study using the nationally representative mortality
data in China. Popul Health Metr 2015;13:16.
Wang L, Wang LJ, Cai Y, et al. [Analysis of under-reporting of
mortality surveillance from 2006 to 2008 in China]. Zhonghua Yu
Fang Yi Xue Za Zhi 2011;45:1061–4.
Hill K, Lopez AD, Shibuya K, et al. Interim measures for meeting
needs for health sector data: births, deaths, and causes of death.
Lancet 2007;370:1726–35.
Rajaratnam JK, Marcus JR, Flaxman AD, et al. Neonatal,
postneonatal, childhood, and under-5 mortality for 187 countries,
1970–2010: a systematic analysis of progress towards Millennium
Development Goal 4. Lancet 2010;375:1988–2008.
Brenner H. Use and limitations of the capture-recapture method in
disease monitoring with two dependent sources. Epidemiology
1995;6:42–8.

7

Downloaded from http://bmjopen.bmj.com/ on May 11, 2016 - Published by group.bmj.com

Analysis of health service amenable and
non-amenable mortality before and since
China's expansion of health coverage in 2009
Xiaoqi Feng, Yunning Liu, Thomas Astell-Burt, Peng Yin, Andrew Page,
Shiwei Liu, Jiangmei Liu, Lijun Wang and Maigeng Zhou
BMJ Open 2016 6:

doi: 10.1136/bmjopen-2015-009370
Updated information and services can be found at:
http://bmjopen.bmj.com/content/6/1/e009370

These include:

References

This article cites 37 articles, 3 of which you can access for free at:
http://bmjopen.bmj.com/content/6/1/e009370#BIBL

Open Access

This is an Open Access article distributed in accordance with the Creative
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work
non-commercially, and license their derivative works on different terms,
provided the original work is properly cited and the use is
non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Email alerting
service

Receive free email alerts when new articles cite this article. Sign up in the
box at the top right corner of the online article.

Topic
Collections

Articles on similar topics can be found in the following collections
Epidemiology (1500)
Public health (1525)

Notes

To request permissions go to:
http://group.bmj.com/group/rights-licensing/permissions
To order reprints go to:
http://journals.bmj.com/cgi/reprintform
To subscribe to BMJ go to:
http://group.bmj.com/subscribe/

